Khelvin Jocson/LinkedIn
Feb 5, 2026, 09:00
Khelvin Jocson: Using LPA to Guide Aspirin Decisions in Primary Prevention
Khelvin Jocson, Advanced Clinical Practitioner in Cardiology at Royal Surrey NHS Foundation Trust, shared a post on LinkedIn about recent article by H. Robert Superko published in American Journal of Preventive Cardiology adding:
“Suggests aspirin guidelines in primary prevention need to be more individualised, rather than one-size-fits-all mindset, with LPA helping to guide that choice.”
Title: The aspirin heart disease prevention conundrum
Authors: H. Robert Superko, John Sninsky, Brenda Garrett
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 24, 2026, 17:12Ron DePinho: CRISPR Progress in Cellular Immunotherapy
-
Mar 24, 2026, 17:12Martine Gilard։ Women’s Heart Health as a National Priority
-
Mar 24, 2026, 17:11Erik Nelson։ Blood Vessels – The Silent System That Determines How You Age
-
Mar 24, 2026, 17:10Anthony Yazbeck: Why the Hemolysin Test Matters More Than You Think
-
Mar 24, 2026, 17:09Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
-
Mar 24, 2026, 17:06Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
-
Mar 24, 2026, 17:01Victor Canata: Is Embolectomy the Best Treatment for Pulmonary Thromboembolism?
-
Mar 24, 2026, 16:57Hossam Qassem: The Stepwise Investigation Framework for ICU Hemoglobin Drop
-
Mar 24, 2026, 16:56Alan Nurden: Targeting Splice Site Variants in Alport Syndrome with Antisense Therapy